Freenome
People in the News at the Chinese University of Hong Kong, Freenome, Burning Rock, Accellix, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Freenome to Lay off 20 Percent of Workforce
The cancer early detection firm disclosed the layoffs in a post on LinkedIn, stating that they are necessary to its realignment of strategic priorities.
Investors React to Initial Data on Freenome's Blood-Based Colon Cancer Detection Test
The company's trial results fell short of what some investors had predicted, easing competition concerns for both Guardant Health and Exact Sciences.
Freenome Raises $254M From Roche, Other Investors to Advance Cancer Early Detection Tests
The new funding will allow the firm to further develop its single- and multi-cancer early cancer detection tests that run on its multiomics platform.
Top Five Articles on GenomeWeb Last Week: Invitae, Tome Biosciences, Oncotype Dx Studies, More
Last week, GenomeWeb's readers were most interested in Invitae's divestiture of its Ciitizen Health data platform.
Jan 11, 2022
Freenome Nets $290M Investment From Roche
Dec 7, 2021
Freenome Raises $300M in Series D Financing
Sep 30, 2021
May 28, 2020
Aug 29, 2019
Jul 24, 2019